The Children’s Tumor Foundation (CTF) is the drug discovery engine for NF. Everything we do is to bring treatments to patients as we work toward a cure. By connecting patients, doctors, scientists, and pharma, we drive treatments, advance care, and deliver results for millions affected by neurofibromatosis or schwannomatosis, collectively referred to as NF. Our patient-first approach accelerates drug development and brings life-changing therapies to patients faster, driven by our mission to end NF.
NF refers to a group of genetic conditions that cause tumors to grow on nerves throughout the body. NF affects 1 in 2,000 births and may lead to blindness, deafness, bone abnormalities, disfigurement, learning disabilities, disabling pain, or cancer. NF affects all races, ethnic groups, and genders equally. NF includes neurofibromatosis type 1 (NF1) and all types of schwannomatosis (SWN), including NF2-related schwannomatosis (NF2-SWN), formerly called neurofibromatosis type 2 (NF2).
Shared 1 month ago
204 views
Shared 1 month ago
63 views
Shared 1 month ago
103 views
Shared 1 month ago
62 views
Shared 1 month ago
32 views
Shared 1 month ago
62 views
Shared 1 month ago
29 views
Shared 1 month ago
37 views
Shared 1 month ago
67 views
Shared 1 month ago
73 views
Shared 1 month ago
30 views
Shared 1 month ago
88 views
Shared 1 month ago
112 views
Shared 1 month ago
29 views
Shared 1 month ago
39 views
Shared 1 month ago
46 views
Shared 1 month ago
24 views
Shared 1 month ago
103 views
Shared 1 month ago
60 views
Shared 1 month ago
38 views
Shared 1 month ago
102 views
Shared 1 month ago
12 views
Shared 1 month ago
52 views
Shared 1 month ago
88 views
Shared 3 months ago
153 views
Shared 3 months ago
47 views
Shared 4 months ago
295 views
Shared 4 months ago
519 views
Shared 5 months ago
101 views
Shared 5 months ago
384 views
Shared 6 months ago
377 views
Shared 7 months ago
177 views
Shared 7 months ago
59 views
Shared 8 months ago
92 views
Shared 8 months ago
139 views
Shared 8 months ago
97 views
Shared 8 months ago
65 views
Shared 9 months ago
66 views
Shared 9 months ago
245 views
Shared 9 months ago
1K views